The present invention provides a pharmaceutical combination composition comprising per unit dose form: i) AT1- antagonist valsartan or a pharmaceutically acceptable salt thereof and ii) a calcium channel blocker which is amlodipine or a pharmaceutically acceptable salt thereof and iii) a pharmaceutically acceptable carrier.